Keyphrases
COVID-19
100%
SARS-CoV-2 Infection
100%
SARS-CoV-2 Replication
100%
Petasites Hybridus
100%
CO2 Extract
100%
Omicron Variant
66%
Normal Human Bronchial Epithelial Cells
66%
Disease Progression
33%
Genome-wide Microarray
33%
Interferon-α (IFN-α)
33%
Treatment Options
33%
Post-infection
33%
Protective Effect
33%
Potential Treatments
33%
Live Cell Imaging
33%
Infection Rate
33%
Low Threshold
33%
Herbal
33%
Antiviral Activity
33%
SARS-CoV-2 Omicron
33%
Antiviral Drugs
33%
Pregenomic RNA (pgRNA)
33%
SARS-CoV-2 Virus
33%
Long COVID
33%
Plaque Assay
33%
Airway Epithelial Cells
33%
RNA Content
33%
Western Countries
33%
Human Transcriptome
33%
IFN Response
33%
Replication Rate
33%
Intrinsic Immune Response
33%
Age of Infection
33%
Cell-intrinsic
33%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
SARS Coronavirus
100%
Petasites
100%
Carbon Dioxide
100%
Normal Human
20%
Antivirus Agent
20%
Cellular Imaging
10%
Disease Exacerbation
10%
Transcriptome
10%
Virus RNA
10%
Interferon
10%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Petasites
100%
Omicron Coronavirus Variant
28%
Normal Human
28%
Interferon Type I
14%
Virus
14%
Transcriptome
14%
COVID-19
14%
Postcovid Syndrome
14%
Immune Response
14%
Wild Type
14%
Cellular Imaging
14%
Airway
14%
Biochemistry, Genetics and Molecular Biology
SARS Coronavirus
100%
Petasites
100%
Normal Human
28%
RNA
14%
Wild Type
14%
Cellular Imaging
14%
Immune Response
14%
Interferon
14%
Transcriptome
14%